Aesthetic Medical International Holdings Group Limited (PAIYY)
OTCMKTS: PAIYY · Delayed Price · USD
0.525
+0.015 (2.94%)
Jun 21, 2024, 4:00 PM EDT - Market closed
PAIYY Revenue
In the year 2023, Aesthetic Medical International Holdings Group had annual revenue of $96.27M with 0.14% growth.
Revenue (ttm)
$96.27M
Revenue Growth
+2.31%
P/S Ratio
0.51
Revenue / Employee
$74,864
Employees
1,286
Market Cap
49.37M
Revenue Chart
* The company reports in CNY currency but revenue data is shown in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 96.27M | 135.30K | 0.14% |
| Dec 31, 2022 | 96.14M | -4.73M | -4.69% |
| Dec 31, 2021 | 100.87M | -36.98M | -26.83% |
| Dec 31, 2020 | 137.86M | 13.71M | 11.04% |
| Dec 31, 2019 | 124.15M | 13.98M | 12.68% |
| Dec 31, 2018 | 110.17M | 4.76M | 4.51% |
| Dec 31, 2017 | 105.42M | 20.66M | 24.37% |
| Dec 31, 2016 | 84.76M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 379.49B |
| Johnson & Johnson | 81.80B |
| Merck & Co. | 61.40B |
| AbbVie | 54.40B |
| Novartis AG | 49.92B |
| AstraZeneca | 47.61B |
| Thermo Fisher | 42.49B |
| Abbott Laboratories | 40.33B |
PAIYY News
- 5 weeks ago - Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Delisting Decision from the Nasdaq Hearings Panel - GlobeNewsWire
- 2 months ago - Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Decision from the Nasdaq Hearings Panel for Conditional Continued Listing - GlobeNewsWire
- 2 months ago - Aesthetic Medical International to Announce FY2023 Annual Report on April 25, 2024 - GlobeNewsWire
- 3 months ago - Aesthetic Medical International Holdings Group Ltd. Announces Receipt of a Letter of Expected Delisting Determination From Nasdaq Staff and Intention to Request a Hearing before the Nasdaq Hearings Panel - GlobeNewsWire
- 6 months ago - Aesthetic Medical International Announces Change of Auditor and Change of Director - GlobeNewsWire
- 10 months ago - Aesthetic Medical International Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency - GlobeNewsWire
- 10 months ago - Aesthetic Medical International Reports First Half of 2023 Unaudited Financial Results - GlobeNewsWire
- 11 months ago - Aesthetic Medical International Announces (i) Closing of Share Transfer, Issue of Conversion Shares, and Issue of Warrants, (ii) Resignations and Appointment of Directors, (iii) Release of Share Pledge, and (iv) Entry into certain Contractual Arrangements with respect to Equity Interests - GlobeNewsWire